Word: biotechs
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...issue as evidence that they represent the reality-based community, running against the theocrats. States from Connecticut to California have tried to step in with enough funding to keep the labs going and slow the exodus of U.S. talent to countries like Singapore, Britain and Taiwan. Meanwhile, private biotech firms and research universities with other sources of funding are free to create and destroy as many embryos as they like, because they operate outside the regulations that follow public funds...
...removed before the cell is fused with the egg. That would ensure that the embryo lives only long enough to produce stem cells and then dies. That strategy, promoted by Dr. William Hurlbut, a member of the President's Council on Bioethics, has its critics. Dr. Robert Lanza of biotech firm Advanced Cell Technology considers it unethical to deliberately create a crippled human embryo "not for a scientific or medical reason, but purely to address a religious issue." The most exciting new possibility doesn't go near embryos at all. Dr. Shinya Yamanaka of Kyoto University reported tantalizing success...
...could control their blood sugar with new pancreatic islet cells. But so far, no human ESCs have been differentiated reliably enough that they could be safely transplanted into people, although animal studies with human cells are under way. Not surprisingly, the groups closest to human trials are in the biotech industry, which operates without government funds. Geron claims it is close to filing for permission to conduct the first human trials relying on ESC-based therapy. It is using stem cells to create oligodendroglial progenitor cells, which produce neurons and provide myelin insulation for the long fingers that extend...
...group of seven asymmetrical buildings with sci-fi names like Nanos and Proteos, all connected by transparent sky bridges, Biopolis is meant to be a self-enclosed science city, housing government research institutes, biotech start-ups and global drug companies. At the ground level, researchers from some 50 countries meet and mingle over spicy laksa noodles, Philly cheesesteaks and German beer, discussing projects in English, the most widely spoken language in the multiethnic city. Inside, the well-stocked labs positively gleam. Ng Huck Hui, a team leader at the Genome Institute of Singapore, points to an expensive array of semiconductors...
...chaired by Cambridge University--based stem-cell scientist Roger Pederson, which will set aside $45 million for research in the field over the next three years. Money also comes from university grants and offshore organizations like the U.S.-based Juvenile Diabetes Research Foundation. The diabetes group has helped fund biotech start-up ES Cell International (ESI), home to Briton--and now Singapore resident--Alan Colman, who was part of the British team that cloned Dolly the sheep in 1996. ESI manufactures its own embryonic-stem-cell lines and is working on shaping those cells into insulin-producing pancreatic tissue...